JP2015520165A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520165A5 JP2015520165A5 JP2015512903A JP2015512903A JP2015520165A5 JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5 JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015512903 A JP2015512903 A JP 2015512903A JP 2015520165 A5 JP2015520165 A5 JP 2015520165A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- formula
- process according
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648534P | 2012-05-17 | 2012-05-17 | |
| US61/648,534 | 2012-05-17 | ||
| PCT/US2013/041687 WO2013173779A1 (en) | 2012-05-17 | 2013-05-17 | Process for making amino acid compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015520165A JP2015520165A (ja) | 2015-07-16 |
| JP2015520165A5 true JP2015520165A5 (enExample) | 2016-06-30 |
| JP6196294B2 JP6196294B2 (ja) | 2017-09-13 |
Family
ID=48483247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512903A Active JP6196294B2 (ja) | 2012-05-17 | 2013-05-17 | アミノ酸化合物を製造するためのプロセス |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9278917B2 (enExample) |
| EP (1) | EP2850054B1 (enExample) |
| JP (1) | JP6196294B2 (enExample) |
| KR (1) | KR102074535B1 (enExample) |
| CN (1) | CN104520263B (enExample) |
| AU (1) | AU2013262516B2 (enExample) |
| BR (1) | BR112014028585B1 (enExample) |
| CA (1) | CA2873658C (enExample) |
| ES (1) | ES2668477T3 (enExample) |
| HR (1) | HRP20180948T1 (enExample) |
| IL (1) | IL235630A (enExample) |
| MA (1) | MA37751B1 (enExample) |
| MX (1) | MX350443B (enExample) |
| MY (1) | MY171538A (enExample) |
| NZ (1) | NZ702939A (enExample) |
| PL (1) | PL2850054T3 (enExample) |
| RU (1) | RU2643146C2 (enExample) |
| SG (1) | SG11201407625WA (enExample) |
| SI (1) | SI2850054T1 (enExample) |
| TR (1) | TR201807444T4 (enExample) |
| WO (1) | WO2013173779A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013173768A1 (en) | 2012-05-17 | 2013-11-21 | Array Biopharma Inc. | Process for making hydroxylated cyclopentylpyrimidine compounds |
| JP6214636B2 (ja) | 2012-05-17 | 2017-10-18 | アレイ バイオファーマ、インコーポレイテッド | ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス |
| KR20240066293A (ko) | 2012-05-17 | 2024-05-14 | 제넨테크, 인크. | 무정형 형태의 akt 저해성 피리미디닐 - 사이클로펜탄 화합물, 조성물 및 이들의 방법 |
| MX354373B (es) | 2012-05-17 | 2018-02-28 | Genentech Inc | Proceso para hacer compuestos de ciclopentapirimidina hidroxilada y sus sales. |
| MX367620B (es) * | 2013-11-15 | 2019-08-28 | Hoffmann La Roche | Procesos para la preparación de compuestos de pirimidinilciclopentano. |
| MX380718B (es) * | 2014-09-26 | 2025-03-12 | Hoffmann La Roche | Procesos para preparar compuestos de (ciclopentil[d]pirimidin-4-il)piperazina |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| BR9408197A (pt) | 1993-12-12 | 1997-08-26 | Agrogene Ltd | Método para proteger plantas contra doenças fúngicas |
| JP2001524079A (ja) | 1997-04-07 | 2001-11-27 | メルク エンド カンパニー インコーポレーテッド | ガンの治療方法 |
| US6201023B1 (en) | 1997-06-10 | 2001-03-13 | Agrogene Ltd. | Methods and compositions to protect crops against plant parasitic nematodes |
| EP0982300A3 (en) | 1998-07-29 | 2000-03-08 | Societe Civile Bioprojet | Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| EP1158982A4 (en) | 1999-03-03 | 2002-06-12 | Merck & Co Inc | Prenyl protein transferase inhibitors |
| AU7715300A (en) | 1999-09-27 | 2001-04-30 | Merck & Co., Inc. | Method of preventing osteoporosis |
| EP1636200A2 (en) | 2003-06-09 | 2006-03-22 | Boehringer Ingelheim International GmbH | Inhibitors of papilloma virus |
| FR2892416B1 (fr) * | 2005-10-20 | 2008-06-27 | Sanofi Aventis Sa | Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique |
| US8927546B2 (en) | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
| UA95641C2 (xx) * | 2006-07-06 | 2011-08-25 | Эррей Биофарма Инк. | Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы |
| US8063050B2 (en) * | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
| US20100298289A1 (en) | 2007-10-09 | 2010-11-25 | Ucb Pharma, S.A. | Heterobicyclic compounds as histamine h4-receptor antagonists |
| US9278922B2 (en) | 2009-04-15 | 2016-03-08 | Abbvie Inc. | Anti-viral compounds |
| AU2010310786B2 (en) | 2009-10-23 | 2014-03-27 | Eli Lilly And Company | AKT inhibitors |
| WO2012009649A1 (en) | 2010-07-16 | 2012-01-19 | Anderson Gaweco | Mif inhibitors and their uses |
| WO2012177925A1 (en) | 2011-06-21 | 2012-12-27 | The Board Institute, Inc. | Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene |
| MX354373B (es) | 2012-05-17 | 2018-02-28 | Genentech Inc | Proceso para hacer compuestos de ciclopentapirimidina hidroxilada y sus sales. |
| JP6214636B2 (ja) | 2012-05-17 | 2017-10-18 | アレイ バイオファーマ、インコーポレイテッド | ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス |
| US20140121193A1 (en) | 2012-11-01 | 2014-05-01 | Robert S. Katz | Methods for treating fibromyalgia |
| US20150376198A1 (en) | 2013-02-18 | 2015-12-31 | The Scripps Research Institute | Modulators of vasopressin receptors with therapeutic potential |
| EP2968318A4 (en) | 2013-03-15 | 2016-12-14 | Shifa Biomedical Corp | ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES |
-
2013
- 2013-05-17 AU AU2013262516A patent/AU2013262516B2/en active Active
- 2013-05-17 RU RU2014150991A patent/RU2643146C2/ru active
- 2013-05-17 US US14/401,095 patent/US9278917B2/en active Active
- 2013-05-17 PL PL13724711T patent/PL2850054T3/pl unknown
- 2013-05-17 NZ NZ702939A patent/NZ702939A/en not_active IP Right Cessation
- 2013-05-17 SG SG11201407625WA patent/SG11201407625WA/en unknown
- 2013-05-17 BR BR112014028585-3A patent/BR112014028585B1/pt active IP Right Grant
- 2013-05-17 EP EP13724711.0A patent/EP2850054B1/en active Active
- 2013-05-17 CA CA2873658A patent/CA2873658C/en active Active
- 2013-05-17 CN CN201380037572.0A patent/CN104520263B/zh active Active
- 2013-05-17 MY MYPI2014703417A patent/MY171538A/en unknown
- 2013-05-17 MA MA37751A patent/MA37751B1/fr unknown
- 2013-05-17 TR TR2018/07444T patent/TR201807444T4/tr unknown
- 2013-05-17 JP JP2015512903A patent/JP6196294B2/ja active Active
- 2013-05-17 WO PCT/US2013/041687 patent/WO2013173779A1/en not_active Ceased
- 2013-05-17 KR KR1020147035263A patent/KR102074535B1/ko active Active
- 2013-05-17 HR HRP20180948TT patent/HRP20180948T1/hr unknown
- 2013-05-17 MX MX2014013863A patent/MX350443B/es active IP Right Grant
- 2013-05-17 SI SI201331043T patent/SI2850054T1/en unknown
- 2013-05-17 ES ES13724711.0T patent/ES2668477T3/es active Active
-
2014
- 2014-11-11 IL IL235630A patent/IL235630A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015520165A5 (enExample) | ||
| RU2012103850A (ru) | Би-арил-мета-пиримидиновые ингибиторы киназ | |
| JP2011057686A5 (enExample) | ||
| JP2007269812A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| JP2012507568A5 (enExample) | ||
| JP2015518892A5 (enExample) | ||
| JP2007522220A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| JP2011513410A5 (enExample) | ||
| ATE383360T1 (de) | 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h- pyrido(2,3-d)pyrimidinderivate und verwandte verbindungen zur behandlung von krebs | |
| JP2009530282A5 (enExample) | ||
| JP2011227454A5 (enExample) | ||
| JP2013500304A5 (enExample) | ||
| MX377235B (es) | Proceso mejorado para preparar bifenilanilidas y bifenilanilinas cloradas. | |
| JP2015518837A5 (enExample) | ||
| AR083105A1 (es) | Metodo para preparar 2-amino-n-(2,2,2-trifluoroetil)acetamida | |
| MX2007007098A (es) | Derivados de pirrol que tienen actividad antagonista del receptor crth2. | |
| RU2014150991A (ru) | Способ получения аминокислотных соединений | |
| JP2015517532A5 (enExample) | ||
| JP2007526383A5 (enExample) | ||
| EP2759540A3 (en) | Beta-3 receptor ligands and their use in therapy | |
| EA201890210A1 (ru) | Гербицидно-активные производные n-(тетразол-5-ил)- и n-(триазол-5-ил)арилкарбоксамида | |
| JP2006518752A5 (enExample) | ||
| JP2012511558A5 (enExample) |